At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
We have now added a new section called the "Assay History List" to the "At A Gla...